Tratamento da hepatite C (2003)
- Authors:
- USP affiliated authors: SILVA, LUIZ CAETANO DA - FM ; CARRILHO, FLAIR JOSE - FM ; NITA, SUZANE KIOKO ONO - FM
- Unidade: FM
- Assunto: HEPATITE C
- Language: Português
- Imprenta:
- ISBN: 85-7378-138-6
- Source:
- Título do periódico: Hepatites agudas e crônicas
-
ABNT
SILVA, Luiz Caetano da et al. Tratamento da hepatite C. Hepatites agudas e crônicas. Tradução . São Paulo: Sarvier, 2003. . . Acesso em: 19 set. 2024. -
APA
Silva, L. C. da, Fonseca, L. E. P. da, Nita, S. K. O., & Carrilho, F. J. (2003). Tratamento da hepatite C. In Hepatites agudas e crônicas. São Paulo: Sarvier. -
NLM
Silva LC da, Fonseca LEP da, Nita SKO, Carrilho FJ. Tratamento da hepatite C. In: Hepatites agudas e crônicas. São Paulo: Sarvier; 2003. [citado 2024 set. 19 ] -
Vancouver
Silva LC da, Fonseca LEP da, Nita SKO, Carrilho FJ. Tratamento da hepatite C. In: Hepatites agudas e crônicas. São Paulo: Sarvier; 2003. [citado 2024 set. 19 ] - Rapid and profound drop HCV RNA viremia induced by high dose of consensus IFN (CIFN) just before starting pegylated interferon (PEG-IFN) plus ribavirin (RBV) in chronic hepatitits C patients (pts) previously resistant to combined therapy (IFN+RBV): preliminary report
- Unpredictable outcome in lamivudine (LAM): resistant patients under high daily doses & early effects of combined therapy of lam plus pegylated interferon
- High resistance to therapy in cirrhotic patients carrying HCV-RNA genotype 3
- High resistance to therapy in cirrhotic patients carrying HCV RNA genotype 3.
- Cinética viral e resultados tardios do tratamento com consensus interferon a (CIFN) e ribavirina (RB) em pacientes com hepatite crônica C (HC-C) previamente resistentes à associação com IFN a e RB
- High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study
- A twelve-week period of follow-up after an end of treatment response (ETR) in patients with chronic hepatitis C (CH-C) submitted to combined therapy is a reliable period to characterize a sustained response
- Early clearance kinetics of hepatitis C virus (HCV) in patients with chronic hepatitis C under therapy with pegylated-interferon (PEG-IFN) alpha-2b or consensus-interferon (CIFN) plus ribavirin
- Unpredictable outcome in lamivudine P-resistant patients under high daily doses and early effects of combined therapy of lamivudine plus pegylated.
- Tratamento das hepatites virais B e D
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas